Want to see HK:8161 full AI Analyst Report?
MediNet Group Ltd. (8161) Ratios
MediNet Group Ltd. Ratios
HK:8161's free cash flow for Q4 2025 was $-384.00K. For the 2025 fiscal year, HK:8161's free cash flow was decreased by $-108.00K and operating cash flow was $-276.00K. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.82 | 0.74 | 0.82 | 0.91 | 1.03 |
| Quick Ratio | 0.80 | 0.72 | 0.80 | 0.90 | 1.01 |
| Cash Ratio | 0.36 | 0.38 | 0.48 | 0.56 | 0.61 |
| Solvency Ratio | 0.16 | 0.42 | 0.04 | -0.37 | 0.25 |
| Operating Cash Flow Ratio | 0.05 | 0.14 | 0.12 | 0.37 | 0.28 |
| Short-Term Operating Cash Flow Coverage | 0.12 | 0.67 | 0.52 | 1.60 | 0.95 |
| Net Current Asset Value | $ -5.83M | $ -13.60M | $ -9.60M | $ -6.25M | $ -5.20M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.31 | 0.35 | 0.38 | 0.23 | 0.19 |
| Debt-to-Equity Ratio | 1.38 | 1.56 | 4.39 | 0.84 | 0.35 |
| Debt-to-Capital Ratio | 0.58 | 0.61 | 0.81 | 0.46 | 0.26 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 4.39 | 4.45 | 11.57 | 3.65 | 1.86 |
| Debt Service Coverage Ratio | 0.36 | 2.11 | 0.25 | -1.60 | 1.02 |
| Interest Coverage Ratio | -8.00 | 13.47 | -7.75 | -19.42 | -11.46 |
| Debt to Market Cap | 0.48 | 0.55 | 0.53 | 0.52 | 0.17 |
| Interest Debt Per Share | 0.29 | 0.45 | 0.40 | 0.25 | 0.32 |
| Net Debt to EBITDA | 0.33 | 0.24 | -0.57 | 0.50 | -0.34 |
| Profitability Margins | |||||
| Gross Profit Margin | 9.03% | 51.85% | 13.07% | 51.35% | 54.05% |
| EBIT Margin | -4.62% | 8.22% | -6.31% | -22.56% | -5.03% |
| EBITDA Margin | 4.91% | 16.48% | 2.06% | -10.51% | 6.66% |
| Operating Profit Margin | -4.62% | 8.29% | -4.40% | -9.85% | -6.15% |
| Pretax Profit Margin | -3.88% | 7.61% | -6.88% | -23.07% | -5.56% |
| Net Profit Margin | -3.89% | 7.58% | -6.95% | -22.54% | -5.13% |
| Continuous Operations Profit Margin | -3.89% | 7.57% | -6.97% | -22.78% | -5.27% |
| Net Income Per EBT | 100.15% | 99.63% | 101.04% | 97.72% | 92.29% |
| EBT Per EBIT | 83.97% | 91.73% | 156.35% | 234.14% | 90.44% |
| Return on Assets (ROA) | -8.81% | 15.61% | -19.23% | -58.03% | -9.08% |
| Return on Equity (ROE) | -38.72% | 69.48% | -222.52% | -211.62% | -16.89% |
| Return on Capital Employed (ROCE) | -43.89% | 58.33% | -81.79% | -71.60% | -17.45% |
| Return on Invested Capital (ROIC) | -19.66% | 29.55% | -26.35% | -38.13% | -12.19% |
| Return on Tangible Assets | -8.81% | 15.61% | -19.23% | -60.73% | -13.11% |
| Earnings Yield | -14.43% | 57.85% | -50.46% | -199.38% | -13.58% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.76 | 5.05 | 11.48 | 17.24 | 14.31 |
| Payables Turnover | 9.12 | 5.22 | 9.61 | 6.59 | 11.24 |
| Inventory Turnover | 147.59 | 82.62 | 173.93 | 147.15 | 113.07 |
| Fixed Asset Turnover | 13.72 | 8.69 | 10.94 | 8.60 | 6.84 |
| Asset Turnover | 2.27 | 2.06 | 2.77 | 2.57 | 1.77 |
| Working Capital Turnover Ratio | -11.44 | -13.17 | -26.07 | -142.35 | 46.24 |
| Cash Conversion Cycle | 16.46 | 6.85 | -4.10 | -31.76 | -3.74 |
| Days of Sales Outstanding | 53.99 | 72.30 | 31.79 | 21.17 | 25.50 |
| Days of Inventory Outstanding | 2.47 | 4.42 | 2.10 | 2.48 | 3.23 |
| Days of Payables Outstanding | 40.01 | 69.87 | 37.99 | 55.41 | 32.47 |
| Operating Cycle | 56.46 | 76.72 | 33.89 | 23.65 | 28.73 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.03 | 0.12 | 0.11 | 0.25 | 0.17 |
| Free Cash Flow Per Share | 0.03 | 0.12 | 0.04 | 0.23 | 0.16 |
| Dividend Paid and CapEx Coverage Ratio | 5.32 | 17.51 | 1.58 | 14.49 | 9.35 |
| Capital Expenditure Coverage Ratio | 5.32 | 17.51 | 1.58 | 14.49 | 9.35 |
| Operating Cash Flow Coverage Ratio | 0.12 | 0.28 | 0.28 | 1.05 | 0.56 |
| Operating Cash Flow to Sales Ratio | 0.02 | 0.05 | 0.04 | 0.09 | 0.06 |
| Free Cash Flow Yield | 4.86% | 34.60% | 10.08% | 77.31% | 14.10% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.93 | 1.76 | -1.98 | -0.50 | -7.36 |
| Price-to-Sales (P/S) Ratio | 0.27 | 0.13 | 0.14 | 0.11 | 0.38 |
| Price-to-Book (P/B) Ratio | 2.68 | 1.20 | 4.41 | 1.06 | 1.24 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 20.57 | 2.89 | 9.92 | 1.29 | 7.09 |
| Price-to-Operating Cash Flow Ratio | 16.70 | 2.73 | 3.64 | 1.20 | 6.34 |
| Price-to-Earnings Growth (PEG) Ratio | 0.05 | -0.01 | 0.03 | -0.00 | 0.03 |
| Enterprise Value Multiple | 5.82 | 1.04 | 6.13 | -0.58 | 5.33 |
| Enterprise Value | 23.81M | 18.18M | 14.65M | 6.73M | 43.01M |
| EV to EBITDA | 5.82 | 1.04 | 6.13 | -0.58 | 5.33 |
| EV to Sales | 0.29 | 0.17 | 0.13 | 0.06 | 0.36 |
| EV to Free Cash Flow | 21.80 | 3.77 | 9.08 | 0.70 | 6.67 |
| EV to Operating Cash Flow | 17.70 | 3.56 | 3.33 | 0.65 | 5.95 |
| Tangible Book Value Per Share | 0.19 | 0.27 | 0.08 | 0.23 | 0.37 |
| Shareholders’ Equity Per Share | 0.20 | 0.28 | 0.09 | 0.28 | 0.88 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.00 | -0.01 | 0.01 | 0.05 |
| Revenue Per Share | 2.00 | 2.56 | 2.79 | 2.65 | 2.91 |
| Net Income Per Share | -0.08 | 0.19 | -0.19 | -0.60 | -0.15 |
| Tax Burden | 1.00 | 1.00 | 1.01 | 0.98 | 0.92 |
| Interest Burden | 0.84 | 0.93 | 1.09 | 1.02 | 1.11 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.14 | 0.19 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.41 | 0.63 | -0.54 | -0.41 | -1.07 |
Currency in HKD